Pulmonary lymphomatoid granulomatosis in a patient with long-term use of a tumour necrosis factor-α inhibitor.
BMJ Case Rep
; 16(5)2023 May 09.
Article
in English
| MEDLINE | ID: covidwho-2317052
ABSTRACT
A man in his 60s presented with intermittent constitutional symptoms along with waxing and waning chest radiographic abnormalities, eventually leading to a diagnosis of lymphomatoid granulomatosis (LYG). LYG is a rare, progressive Epstein-Barr virus (EBV)-driven lymphoproliferative disease associated with immune dysregulation most commonly involving the lungs. The diagnosis requires tissue biopsy; thus, the decision to pursue tissue sampling with histopathology examination in a timely manner is essential. Currently, there are no established guidelines regarding the treatment of LYG, which varies from cessation of immunosuppressants to immunochemotherapy and usually requires multidisciplinary team discussion.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Epstein-Barr Virus Infections
/
Lymphomatoid Granulomatosis
Type of study:
Case report
/
Diagnostic study
Topics:
Long Covid
Limits:
Humans
/
Male
Language:
English
Year:
2023
Document Type:
Article
Affiliation country:
Bcr-2022-254211
Similar
MEDLINE
...
LILACS
LIS